Paloma Health
PrivateLast Round
Accelerator
Sep 16, 2024
Total Funding Raised
$25,000
Company Overview
Paloma Health is a healthcare services company that provides NHS-funded autism and ADHD assessments for children and young people in England.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Patient Engagement, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paloma Health Comparables
Compare Paloma Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allara Health | 79% | |
| Hashiona | 77% | |
| Everly Health | 69% | |
Paloma Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 16, 2024 |
Paloma Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Healthworx | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Grew 18% QoQ, from 72 to 85 employees.
- Apr 17, 2026
Grew 16% QoQ, from 70 to 81 employees.
Paloma Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paloma Health's valuation, stock price, and market status.